Immunity during monochemotherapy with mitoxantrone: preliminary results.
Cartei
G
G
Division of Medical Oncology, Ospedale S.Maria delle Misericordia, Udine, Italy.
Contessi
E
E
Comelli
M
M
Turrin
D
D
Toso
C
C
Sibau
A
A
Mian
S
S
Bramezza
M
M
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000880:Anthraquinones / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000276:immunology; D006801:Humans; D007958:Leukocyte Count; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D008297:Male; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D011446:Prospective Studies
D000276:Adjuvants, Immunologic; D000880:Anthraquinones; D000970:Antineoplastic Agents; D008942:Mitoxantrone